Hydrochloric Acid → (2S)-2-methyl-1-(2-pyridinylcarbonyl)piperazine dihydrochloride

HRID 41303

반응식

HRID 41303 반응식
C[C@@H]1NCCN(C(OC(C)(C)C)=O)C1.CCN(C(C)C)C(C)C.N1C=CC=CC=1C([Cl:32])=O.[CH3:33][C@@H:34]1[N:39]([C:40]([C:42]2[CH:47]=[CH:46][CH:45]=[CH:44][N:43]=2)=[O:41])[CH2:38][CH2:37][N:36](C(OC(C)(C)C)=O)[CH2:35]1.[ClH:55]>ClCCl.O.O1CCOCC1>[ClH:32].[ClH:55].[CH3:33][C@H:34]1[CH2:35][NH:36][CH2:37][CH2:38][N:39]1[C:40]([C:42]1[CH:47]=[CH:46][CH:45]=[CH:44][N:43]=1)=[O:41]

참가 물질

9

실험 절차

To a solution 1,1-dimethylethyl (3S)-3-methyl-1-piperazinecarboxylate (140 mg, 0.699 mmol) in dichloromethane (5 ml) was added DIPEA (0.183 ml, 1.049 mmol) at room temperature. 2-pyridinecarbonyl chloride (104 mg, 0.735 mmol) was then added and the resultant mixture stirred for 3 h30. The reaction mixture was then diluted with a further 2 ml DCM and 5 ml of water were added and the layers separated, the organics were then washed with 5 ml 2M HCl solution and 5 ml sat NaHCO3 solution then dried (hydrophobic frit) and concentrated to dryness. To a solution of the resulting 1,1-dimethylethyl (3S)-3-methyl-4-(2-pyridinylcarbonyl)-1-piperazinecarboxylate (78 mg, 0.255 mmol) in 1,4-Dioxane (1 ml) was added HCl (4M in 1,4-Dioxane) (0.319 ml, 1.277 mmol) at room temperature and the resultant mixture stirred overnight at room temperature. Reaction mixture concentrated to dryness and solid triturated with diethylether to give the title compound (71 mg) used without further purification.

후처리

  1. additionwere added
  2. customthe layers separated
  3. washthe organics were then washed with 5 ml 2M HCl solution and 5 ml
  4. customthen dried (hydrophobic frit)
  5. concentrationconcentrated to dryness
  6. customReaction mixture
  7. concentrationconcentrated to dryness and solid
  8. customtriturated with diethylether

출처 및 근거

ORD 기록
ord-3ec05c3eb13147cc824496add55593c4
출처 데이터셋
uspto-grants-2013_09
특허 번호
US08530478B2

연결된 노트

불러오는 중…